CLOV insider trading — Clover Health Investments, Corp.
Over the last 90 days, insiders at Clover Health Investments, Corp. (CLOV) made 0 open-market purchases worth $0 and 1 open-market sale worth $103K, making them net sellers by $103K. The largest sale was by Oldakowski Joseph Frank (VP OF FINANCE AND CONTROLLER), who sold 20,000 shares for $103K on Sep 14, 2026.
Updated Oct 16, 2026.
Recent CLOV insider transactions
Every Form 4 filed by Clover Health Investments, Corp. officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 7, 2026 | Reynoso Jamie L. | CEO, Medicare Advantage | S · Sale · 10b5-1 | Direct | 2,006 | $4.63 | $9K | Form 4 |
| Oct 5, 2026 | Reynoso Jamie L. | CEO, Medicare Advantage | S · Sale · 10b5-1 | Direct | 8,750 | $4.42 | $39K | Form 4 |
| Sep 30, 2026 | Miller Brian James | Director | A · Grant/award | Direct | 12,481 | — | — | Form 4 |
| Sep 30, 2026 | Torricelli Robert G | Director | A · Grant/award | Direct | 12,481 | — | — | Form 4 |
| Oct 1, 2026 | Toy Andrew | Chief Executive Officer | S · Sale · 10b5-1 | Direct | 318,806 | $4.19 | $1.34M | Form 4 |
| Sep 17, 2026 | Reynoso Jamie L. | CEO, Medicare Advantage | S · Sale · 10b5-1 | Direct | 1,921 | $4.56 | $9K | Form 4 |
| Sep 16, 2026 | Oldakowski Joseph Frank | VP OF FINANCE AND CONTROLLER | S · Sale · 10b5-1 | Direct | 3,170 | $4.64 | $15K | Form 4 |
| Sep 15, 2026 | Wai Conrad | CEO, Counterpart Health | S · Sale · 10b5-1 | Indirect | 300,000 | $4.72 | $1.42M | Form 4 |
| Sep 15, 2026 | Soares Karen | Chief Legal Officer | S · Sale · 10b5-1 | Direct | 6,846 | $4.78 | $33K | Form 4 |
| Sep 15, 2026 | Reynoso Jamie L. | CEO, Medicare Advantage | S · Sale · 10b5-1 | Direct | 9,273 | $4.78 | $44K | Form 4 |
| Sep 14, 2026 | Oldakowski Joseph Frank | VP OF FINANCE AND CONTROLLER | S · Sale | Direct | 20,000 | $5.16 | $103K | Form 4 |
| Aug 17, 2026 | Thornton Joseph Clay | Interim CFO | S · Sale · 10b5-1 | Direct | 17,775 | $4.39 | $78K | Form 4 |
| Aug 12, 2026 | Soares Karen | Chief Legal Officer | A · Grant/award | Direct | 108,695 | — | — | Form 4 |
| Aug 12, 2026 | Thornton Joseph Clay | Interim CFO | A · Grant/award | Direct | 54,347 | — | — | Form 4 |
| Aug 10, 2026 | Toy Andrew | Chief Executive Officer | S · Sale · 10b5-1 | Direct | 87,798 | $4.65 | $408K | Form 4 |
| Jul 20, 2026 | Soares Karen | Chief Legal Officer | S · Sale · 10b5-1 | Direct | 51,700 | $4.51 | $233K | Form 4 |
CLOV insider trading FAQ
Are insiders buying CLOV stock?
Not on the open market. In the last 90 days, Clover Health Investments, Corp. insiders made no open-market purchases, and 1 open-market sale totaling $103K. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading CLOV?
Recent sellers: Oldakowski Joseph Frank.
Where does CLOV insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.